Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
9.40
+0.05 (0.53%)
At close: Dec 31, 2025, 4:00 PM EST
9.30
-0.10 (-1.06%)
After-hours: Dec 31, 2025, 7:35 PM EST
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $537.02 million as of December 31, 2025. Its market cap has increased by 181.43% in one year.
Market Cap
537.02M
Enterprise Value
370.90M
1-Year Change
181.43%
Ranking
Category
Stock Price
$9.40
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $537.02M, a decrease of -40.20%. That is a compound annual growth rate of -23.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 537.02M | 232.60% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |